¼¼°èÀÇ ¸¸¼º Áúȯ °ü¸® ½ÃÀå : Áúȯ À¯Çüº°, ¼ºñ½º À¯Çüº°, ¹èÆ÷ ¸ðµåº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°
Chronic Disease Management Market, By Disease Type, By Service Type, By Delivery Mode, By End User, By Geography
»óǰÄÚµå
:
1705700
¸®¼Ä¡»ç
:
Coherent Market Insights
¹ßÇàÀÏ
:
2025³â 02¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹®
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
¼¼°èÀÇ ¸¸¼º Áúȯ °ü¸® ½ÃÀåÀº 2025³â 64¾ï 9,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ°í, 2032³â±îÁö 158¾ï 5,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025³âºÎÅÍ 2032³â±îÁö CAGR 13.6%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.
º¸°í ¹üÀ§
º¸°í¼ ¼¼ºÎÁ¤º¸
±âÁØ¿¬µµ
2024³â
2025³â ½ÃÀå ±Ô¸ð
64¾ï 9,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ
2020-2024³â
¿¹Ãø ±â°£
2025-2032³â
¿¹Ãø ±â°£: 2025-2032³â CAGR:
13.60%
2032³â °¡Ä¡ ¿¹Ãø
158¾ï 5,000¸¸ ´Þ·¯
±×¸². ¸¸¼º Áúȯ °ü¸® ½ÃÀåÀÇ Áö¿ªº° Á¡À¯À²(%)(2025³â)
´ç´¢º´, ¾Ï, ½ÉÇ÷°ü Áúȯ(CVD), ¸¸¼º Æó»ö¼º Æó Áúȯ(COPD), õ½Ä µîÀÇ ¸¸¼º ÁúȯÀº Áö¼ÓÀûÀÎ ÀǷḦ ÇÊ¿ä·Î Çϰí ÀÏ»ó»ýȰÀ» Á¦ÇÑÇÏ´Â Àå±âÀûÀÎ °Ç°»óÅÂÀÔ´Ï´Ù. ½ºÆ®·¹½º°¡ ¸¹Àº »ýȰÀÌ ÀÌ·¯ÇÑ Áõ»óÀ» °ü¸®Çϱ⠾î·Á¿öÁö°í ÀÖÀ¸¸ç, ÀÌ·Î ÀÎÇØ º¸´Ù ¿ì¼öÇÑ ¸¸¼º Áúȯ °ü¸® ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.
½ÃÀå ¿ªÇÐ:
¼¼°èÀÇ ¸¸¼º Áúȯ °ü¸® ½ÃÀåÀÇ ¼ºÀåÀº º¹¼öÀÇ ¸¸¼º ÁúȯÀ» °¡Áø ³ëÀÎ Àα¸ Áõ°¡, ºñ¸¸°ú ½Ä»ýȰÀÇ º¯È¿¡ ÀÇÇÑ ´ç´¢º´À̳ª ½ÉÇ÷°ü Áúȯ µîÀÇ »ýȰ ½À°üº´ÀÇ ÀÌȯÀ² Áõ°¡, Áúº´ÀÇ Á¶±â ¹ß°ß°ú Áúȯ °ü¸®ÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡, µðÁöÅÐ Çコ ¼Ö·ç¼ÇÀÇ ±â¼ú Áøº¸, ÀÇ·áºñ Áõ°¡¸¦ ¾ïÁ¦Çϱâ À§ÇÑ ´Ù¾çÇÑ Á¤ºÎ³ª ¹Î°£ Á¶Á÷ÀÇ ³ë·Â µîÀÇ ¿äÀο¡ ÀÇÇØ ÃÊ·¡µË´Ï´Ù. ±×·¯³ª, µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã¿¡ ´ëÇÑ ¿ì·Á, ¿ø°Ý ¸ð´ÏÅ͸µ Àåºñ ¹× ¼ºñ½º µµÀÔ ºñ¿ëÀÇ ³ôÀÌ, °³¹ßµµ»ó±¹¿¡¼ÀÇ ¼÷·ÃµÈ ÇコÄɾî Àü¹®°¡ÀÇ ºÎÁ· µîÀÌ, º¸´Ù ½Å¼ÓÇÑ º¸±ÞÀÇ ¹æÇذ¡ µÉ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù.º¹¼öÀÇ º´Å¸¦ °ü¸®ÇÏ´Â ÅëÇÕ Ç÷§ÆûÀÇ °³¹ß, AI¿Í ¿þ¾î·¯ºí ±â¼úÀÇ ¿ªÇÒ È®´ë, °³º°È Äɾ ´ëÇÑ ÁÖ¸ñ »ó½ÂÀÌ ½ÃÀå ±â¾÷¿¡°Ô À¯¸®ÇÑ ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù.
º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡
º» º¸°í¼¿¡¼´Â ¼¼°èÀÇ ¸¸¼ºÁúȯ °ü¸® ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ¿© 2024³âÀ» ±âÁØ¿¬µµ·Î ÇÑ ¿¹Ãø±â°£(2025-2032³â) ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í ¿¬°£ Æò±Õ ¼ºÀå·ü(CAGR%)À» Á¦°øÇÕ´Ï´Ù.
¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀûÀÎ ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç°ÀÇ »ó½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤¿ëÇÏ´Â °æÀï Àü·« µî¿¡ °üÇÑ Áß¿äÇÑ °íÂûµµ Á¦°øÇÕ´Ï´Ù.
¼¼°èÀÇ ¸¸¼º Áúȯ °ü¸® ½ÃÀå¿¡¼ ÁÖ¿ä ±â¾÷À» ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ½ÇÀû, Àü·« µîÀÇ ¸Å°³º¯¼ö¸¦ ±â¹ÝÀ¸·Î ÇÁ·ÎÆÄÀϸµÇϰí ÀÖ½À´Ï´Ù.
º» Á¶»çÀÇ ´ë»óÀÌ µÇ´Â ÁÖ¿ä ±â¾÷¿¡´Â IBM, Cerner Corporation, Epic Systems, McKesson Corporation, Athenahealth, Healthagen, Allscripts, Optum(A Part of UnitedHealth Group), Conifer Health Solutions, NXGN Management, Phytel, I2I Population Health, Healthwise°¡ Æ÷ÇԵ˴ϴÙ.
ÀÌ º¸°í¼ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, ŸÀÌÇÎ, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
¼¼°èÀÇ ¸¸¼ºÁúȯ °ü¸® ½ÃÀå º¸°í¼´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô Âü°¡ÀÚ, À繫 ºÐ¼®°¡ µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ Áö¿øÇÕ´Ï´Ù.
ÀÌÇØ°ü°èÀÚµéÀº ¼¼°èÀÇ ¸¸¼ºÁúȯ °ü¸® ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç °áÁ¤ÀÌ ¿ëÀÌÇØÁý´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç
Á¦2Àå ½ÃÀå Àü¸Á
Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®
½ÃÀå ¿ªÇÐ
¼ºÀå ÃËÁø¿äÀÎ
¾ïÁ¦¿äÀÎ
±âȸ
¿µÇ⠺м®
½ÃÀå µ¿Çâ
ÁÖ¿ä ¹ßÀü
±ÔÁ¦ ½Ã³ª¸®¿À
Àμö¿Í Á¦ÈÞ ½Ã³ª¸®¿À
ÀÚ±Ý Á¶´Þ ¹× ÅõÀÚ
PEST ºÐ¼®
Porter's Five Forces ºÐ¼®
Á¦4Àå ¼¼°èÀÇ ¸¸¼º Áúȯ °ü¸® ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) À¯ÇàÀÇ ¿µÇâ
ÀüüÀûÀÎ ¿µÇâ
Á¤ºÎÀÇ ´ëó
COVID-19¿¡ ÀÇÇÑ ½ÃÀå¿¡ ´ëÇÑ ¿µÇâ
Á¦5Àå ¼¼°èÀÇ ¸¸¼º Áúȯ °ü¸® ½ÃÀå, Áúȯ À¯Çüº°, 2021-2032³â
½ÉÇ÷°ü Áúȯ
´ç´¢º´
È£Èí±â Áúȯ
¾Ï
¸¸¼º ½ÅÀ庴
±âŸ
Á¦6Àå ¼¼°èÀÇ ¸¸¼º Áúȯ °ü¸® ½ÃÀå, ¼ºñ½º À¯Çüº°, 2021-2032³â
Áúº´ °ü¸® ÇÁ·Î±×·¥
¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ
¿ø°Ý ÀÇ·á ¼ºñ½º
±âŸ
Á¦7Àå ¼¼°èÀÇ ¸¸¼º Áúȯ °ü¸® ½ÃÀå, Àü´Þ ¸ðµåº°, 2021-2032³â
¿ÂÇÁ·¹¹Ì½º
À¥ ±â¹Ý
Ŭ¶ó¿ìµå ±â¹Ý
Á¦8Àå ¼¼°èÀÇ ¸¸¼ºÁúȯ °ü¸® ½ÃÀå, ÃÖÁ¾ »ç¿ëÀÚº°, 2021-2032³â
º´¿ø
Àü¹® Ŭ¸®´Ð
ÀçÅà ÄÉ¾î ¼³Á¤
±âŸ
Á¦9Àå ¼¼°èÀÇ ¸¸¼ºÁúȯ °ü¸® ½ÃÀå, Áö¿ªº°, 2021-2032³â
ºÏ¹Ì
¶óƾ¾Æ¸Þ¸®Ä«
À¯·´
¾Æ½Ã¾ÆÅÂÆò¾ç
秵¾ÆÇÁ¸®Ä«
Á¦10Àå °æÀï ±¸µµ
±â¾÷ ÇÁ·ÎÆÄÀÏ
UnitedHealth Group
CVS Health
Cigna
Anthem, Inc.
Aetna(a CVS Health company)
Mayo Clinic
Kaiser Permanente
Humana Inc.
Teladoc Health, Inc.
McKesson Corporation
Cerner Corporation
Epic Systems Corporation
Medtronic
Abbott Laboratories
Novartis AG
Roche Holding AG
Bristol-Myers Squibb
Johns Hopkins Medicine
GE Healthcare
Philips Healthcare
Á¦11Àå ºÐ¼®°¡ Ãßõ
¿î¸íÀÇ ¿ø
¾Ö³Î¸®½ºÆ®ÀÇ °ßÇØ
Àϰü¼º ÀÖ´Â ±âȸ ¸Ê
Á¦12Àå Âü°í¹®Çå°ú Á¶»ç¹æ¹ý
JHS
¿µ¹® ¸ñÂ÷
Global Chronic Disease Management Market is estimated to be valued at USD 6.49 Bn in 2025 and is expected to reach USD 15.85 Bn by 2032, growing at a compound annual growth rate (CAGR) of 13.6% from 2025 to 2032.
Report Coverage
Report Details
Base Year:
2024
Market Size in 2025:
USD 6.49 Bn
Historical Data for:
2020 To 2024
Forecast Period:
2025 To 2032
Forecast Period 2025 to 2032 CAGR:
13.60%
2032 Value Projection:
USD 15.85 Bn
Figure. Chronic Disease Management Market Share (%), By Region 2025
Chronic diseases, such as diabetes, cancer, cardiovascular diseases (CVD), chronic obstructive pulmonary disease (COPD), and asthma are long-term health conditions that require ongoing medical care and limit daily activities. These are largely preventable through lifestyle changes, like avoiding tobacco and maintaining healthy weight. However, busy schedules and stressful lives have made managing such conditions challenging. This has boosted demand for better chronic disease management techniques. Various technological advancements in remote patient monitoring and growing efforts by governments to improve healthcare infrastructure can drive the market growth in the near future.
Market Dynamics:
Global chronic disease management market growth is driven by factors like growing geriatric population burdened by multiple chronic conditions, increasing incidence of lifestyle diseases such as diabetes and cardiovascular diseases due to obesity and changing dietary patterns, growing awareness about benefits of early disease detection and disease management, technological advances in digital health solutions, and initiatives by various governments and private organizations to curb rising healthcare costs. However, data privacy concerns, high deployment costs of remote monitoring devices and services, and lack of skilled healthcare professionals in developing nations can hamper faster adoption. Development of integrated platforms to manage multiple conditions, expanding role of AI and wearable technologies, and growing focus on personalized care provide lucrative growth opportunities for market players.
Key features of the study:
This report provides in-depth analysis of the global chronic disease management market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global chronic disease management market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include IBM, Cerner Corporation, Epic Systems, McKesson Corporation, Athenahealth, Healthagen, Allscripts, Optum (A Part of UnitedHealth Group), Conifer Health Solutions, NXGN Management, Phytel, I2I Population Health, and Healthwise
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global chronic disease management market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global chronic disease management market
Detailed Segmentation-
Disease Type Insights (Revenue, USD Bn, 2020 - 2032)
Cardiovascular Diseases
Diabetes
Respiratory Diseases
Cancer
Chronic Kidney Disease
Others (Arthritis, etc.)
Service Type Insights (Revenue, USD Bn, 2020 - 2032)
Disease Management Programs
Remote Patient Monitoring
Telehealth Services
Others (Diagnostic Services, etc.)
Delivery Mode Insights (Revenue, USD Bn, 2020 - 2032)
On-premise
Web-based
Cloud-based
End User Insights (Revenue, USD Bn, 2020 - 2032)
Hospitals
Specialty Clinics
Home Care Settings
Others (Pharmaceutical Companies, etc.)
Regional Insights (Revenue, USD Bn 2020 - 2032)
North America
U.S.
Canada
Latin America
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
GCC Countries
Israel
Rest of Middle East
Africa
South Africa
North Africa
Central Africa
Key Players Insights
UnitedHealth Group
CVS Health
Cigna
Anthem, Inc.
Aetna (a CVS Health company)
Mayo Clinic
Kaiser Permanente
Humana Inc.
Teladoc Health, Inc.
McKesson Corporation
Cerner Corporation
Epic Systems Corporation
Medtronic
Abbott Laboratories
Novartis AG
Roche Holding AG
Bristol-Myers Squibb
Johns Hopkins Medicine
GE Healthcare
Philips Healthcare
Table of Contents
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Disease Type
Market Snapshot, By Service Type
Market Snapshot, By Delivery Mode
Market Snapshot, By End User
Market Snapshot, By Region
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis
4. Global Chronic Disease Management Market - Impact of Coronavirus (COVID-19) Pandemic
Overall Impact
Government Initiatives
COVID-19 Impact on the Market
5. Global Chronic Disease Management Market, By Disease Type, 2021 - 2032, (USD Bn)
Overview
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Cardiovascular Diseases
Overview
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Diabetes
Overview
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Respiratory Diseases
Overview
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cancer
Overview
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Chronic Kidney Disease
Overview
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Chronic Disease Management Market, By Service Type, 2021 - 2032, (USD Bn)
Overview
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Disease Management Programs
Overview
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Remote Patient Monitoring
Overview
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Telehealth Services
Overview
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Chronic Disease Management Market, By Delivery Mode, 2021 - 2032, (USD Bn)
Overview
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
On-premise
Overview
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Web-based
Overview
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cloud-based
Overview
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Chronic Disease Management Market, By End User, 2021 - 2032, (USD Bn)
Overview
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Hospitals
Overview
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Specialty Clinics
Overview
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Home Care Settings
Overview
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Chronic Disease Management Market, By Region, 2021 - 2032, (USD Bn)
Introduction
Market Share Analysis, By Region, 2025 and 2032 (%)
Y-o-Y Growth Analysis, For Region, 2021-2032
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Bn)
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2032, (USD Bn)
North Africa
Central Africa
South Africa
10. Competitive Landscape
Company Profiles
UnitedHealth Group
Company Highlights
Method Portfolio
Key Highlights
Financial Performance
Market Strategies
CVS Health
Company Highlights
Method Portfolio
Key Highlights
Financial Performance
Market Strategies
Cigna
Company Highlights
Method Portfolio
Key Highlights
Financial Performance
Market Strategies
Anthem, Inc.
Company Highlights
Method Portfolio
Key Highlights
Financial Performance
Market Strategies
Aetna (a CVS Health company)
Company Highlights
Method Portfolio
Key Highlights
Financial Performance
Market Strategies
Mayo Clinic
Company Highlights
Method Portfolio
Key Highlights
Financial Performance
Market Strategies
Kaiser Permanente
Company Highlights
Method Portfolio
Key Highlights
Financial Performance
Market Strategies
Humana Inc.
Company Highlights
Method Portfolio
Key Highlights
Financial Performance
Market Strategies
Teladoc Health, Inc.
Company Highlights
Method Portfolio
Key Highlights
Financial Performance
Market Strategies
McKesson Corporation
Cerner Corporation
Epic Systems Corporation
Medtronic
Abbott Laboratories
Novartis AG
Roche Holding AG
Bristol-Myers Squibb
Johns Hopkins Medicine
GE Healthcare
Philips Healthcare
11. Analyst Recommendations
Wheel of Fortune
Analyst View
Coherent Opportunity Map
12. References and Research Methodology
References
Research Methodology
About us and Sales Contact
°ü·ÃÀÚ·á